Emtricitabine/Tenofovir (FTC/TDF)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Emtricitabine/Tenofovir (FTC/TDF), covering 2018-06-06 to 2018-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults [Phase 3]